Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ADH7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SLC5A7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RASGRF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SOWAHA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
SERPINI2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ACSBG2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HAL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LRRC25 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ACE2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TCTEX1D1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADAMTSL4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HSPB6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EGFR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TAB2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DNTT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on